These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32023055)

  • 21. The drug-target residence time model: a 10-year retrospective.
    Copeland RA
    Nat Rev Drug Discov; 2016 Feb; 15(2):87-95. PubMed ID: 26678621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery.
    Meghani NM; Amin HH; Lee BJ
    Drug Discov Today; 2017 Nov; 22(11):1604-1619. PubMed ID: 28754291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolva breeds small molecule drugs au naturel.
    Wolfson W
    Chem Biol; 2009 Jun; 16(6):577-8. PubMed ID: 19549594
    [No Abstract]   [Full Text] [Related]  

  • 24. Model-based drug discovery: implementation and impact.
    Visser SA; Aurell M; Jones RD; Schuck VJ; Egnell AC; Peters SA; Brynne L; Yates JW; Jansson-Löfmark R; Tan B; Cooke M; Barry ST; Hughes A; Bredberg U
    Drug Discov Today; 2013 Aug; 18(15-16):764-75. PubMed ID: 23726890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
    Decker M
    Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H; Oh DC
    Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological approaches to restore mitochondrial function.
    Andreux PA; Houtkooper RH; Auwerx J
    Nat Rev Drug Discov; 2013 Jun; 12(6):465-83. PubMed ID: 23666487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of engineered therapeutics and medication.
    Wang DA
    Pharm Res; 2011 Jun; 28(6):1237-40. PubMed ID: 21491147
    [No Abstract]   [Full Text] [Related]  

  • 32. Identifying enriched drug fragments as possible candidates for metabolic engineering.
    Sharma S; Karri K; Thapa I; Bastola D; Ghersi D
    BMC Med Genomics; 2016 Aug; 9 Suppl 2(Suppl 2):46. PubMed ID: 27510651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin and Yang in medicinal chemistry: what does drug-likeness mean?
    Macarrón R; Luengo JI
    Future Med Chem; 2011 Apr; 3(5):505-7. PubMed ID: 21526891
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of bioactive natural products by pharmacophore-based virtual screening.
    Schuster D; Wolber G
    Curr Pharm Des; 2010 May; 16(15):1666-81. PubMed ID: 20222852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why so few drug targets: a mathematical explanation?
    Tun K; Menghini M; D'Andrea L; Dhar P; Tanaka H; Giuliani A
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):206-13. PubMed ID: 21599620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional pathway pharmacology: chemical tools, pathway knowledge and mechanistic model-based interpretation of experimental data.
    Hendriks BS
    Curr Opin Chem Biol; 2010 Aug; 14(4):489-97. PubMed ID: 20609614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A screening pattern recognition method finds new and divergent targets for drugs and natural products.
    Wassermann AM; Lounkine E; Urban L; Whitebread S; Chen S; Hughes K; Guo H; Kutlina E; Fekete A; Klumpp M; Glick M
    ACS Chem Biol; 2014 Jul; 9(7):1622-31. PubMed ID: 24802392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.